Clinical Trial Update: Fruquintinib Combined With Adebrelimab and High and Low Dose Radiotherapy in the Treatment of Second-line and Above Failure MSS Metastatic Colorectal Cancer. [NA]

View source ↗

Summary

A clinical trial investigating the combination of Fruquintinib and Adebrelimab with high- or low-dose radiotherapy for second-line and later MSS metastatic colo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)
• Fruquintinib (fruquintinib)

Snippet

Sponsor: Ningbo Medical Center Lihuili Hospital | Conditions: MSS Metastatic Colorectal Cancer | NA | Status: RECRUITING